HIGHLIGHTS
- who: Jiasheng Chen and colleagues from the Department of Burns and Plastic Surgery, The Affiliated Hospital of Shantou University Medical College, Shantou, China have published the research work: NCKAP1 is a Prognostic Biomarker for Inhibition of Cell Growth in Clear Cell Renal Cell Carcinoma, in the Journal: (JOURNAL)
- what: The authors aimed to determine the function of NCKAP1 in ccRCC using bioinformatics analysis portal tools and immunohistochemical validation, to examine the relationship between NCKAP1 expression and clinicopathological features of ccRCC, and to determine the in_vitro and in_vivo NCKAP1 expression was measured to characterize the clinicopathological . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.